September 2022 will be remembered as a seminal turning point for digital health in the U.S. With the FDA’s final guidance on clinical decision support (CDS) software, the FDA disregards a Congressional directive when it enacted the 21st Century Cures Act in 2016.
Latin America is a compelling region to conduct medtech early feasibility studies due to its ethnically diverse population, its high rate of urbanization, and more. Here, the author spotlights Colombia, Brazil, and Mexico as the hotspots for medtech feasibility studies in Latin America.
